04/05/2026
Pleased to share that Dr Asif Malik Humayun is Principal Investigator for a multi-centre clinical trial evaluating rilzabrutinib in Graves’ disease.
This important study aims to explore more targeted treatment options for patients with autoimmune thyroid disease.
A promising step forward in endocrine research.
For more information, please contact: [email protected]